TAB molecules
US8101728B2 · kind B2 · utility
0Cited by
12References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 21, 2006 |
| Grant date | Jan 24, 2012 |
| Priority date | — |
| Expiry date | Mar 13, 2027 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/622
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to TAB molecules, ADEPT constructs directed against TAG-72, and their use in therapy.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.